KR20030007221A - 세포내 과정의 관측 방법 및 그를 위해 사용되는 재조합유전자 - Google Patents
세포내 과정의 관측 방법 및 그를 위해 사용되는 재조합유전자 Download PDFInfo
- Publication number
- KR20030007221A KR20030007221A KR1020020041787A KR20020041787A KR20030007221A KR 20030007221 A KR20030007221 A KR 20030007221A KR 1020020041787 A KR1020020041787 A KR 1020020041787A KR 20020041787 A KR20020041787 A KR 20020041787A KR 20030007221 A KR20030007221 A KR 20030007221A
- Authority
- KR
- South Korea
- Prior art keywords
- protein
- cell
- recombinant gene
- specific
- signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 309
- 238000000034 method Methods 0.000 title claims abstract description 108
- 230000006525 intracellular process Effects 0.000 title abstract description 17
- 238000012544 monitoring process Methods 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 236
- 239000013612 plasmid Substances 0.000 claims abstract description 60
- 230000014509 gene expression Effects 0.000 claims abstract description 54
- 239000000126 substance Substances 0.000 claims abstract description 31
- 238000009826 distribution Methods 0.000 claims abstract description 29
- 230000033001 locomotion Effects 0.000 claims abstract description 17
- 238000002073 fluorescence micrograph Methods 0.000 claims abstract description 7
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 113
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 113
- 239000005090 green fluorescent protein Substances 0.000 claims description 109
- 210000004027 cell Anatomy 0.000 claims description 108
- 108010054624 red fluorescent protein Proteins 0.000 claims description 48
- 102000034287 fluorescent proteins Human genes 0.000 claims description 36
- 108091006047 fluorescent proteins Proteins 0.000 claims description 36
- 230000003834 intracellular effect Effects 0.000 claims description 31
- 210000003463 organelle Anatomy 0.000 claims description 20
- 230000005012 migration Effects 0.000 claims description 19
- 238000013508 migration Methods 0.000 claims description 19
- 210000003934 vacuole Anatomy 0.000 claims description 18
- 210000002472 endoplasmic reticulum Anatomy 0.000 claims description 16
- 150000003904 phospholipids Chemical class 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 16
- 210000002288 golgi apparatus Anatomy 0.000 claims description 12
- 210000001938 protoplast Anatomy 0.000 claims description 11
- 210000003470 mitochondria Anatomy 0.000 claims description 9
- 210000000170 cell membrane Anatomy 0.000 claims description 8
- 210000004940 nucleus Anatomy 0.000 claims description 8
- 101000621451 Arabidopsis thaliana Vesicle transport v-SNARE 11 Proteins 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 238000000799 fluorescence microscopy Methods 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 6
- 210000002824 peroxisome Anatomy 0.000 claims description 4
- 244000124209 Crocus sativus Species 0.000 claims description 3
- 235000015655 Crocus sativus Nutrition 0.000 claims description 3
- 238000001638 lipofection Methods 0.000 claims description 3
- 230000002101 lytic effect Effects 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 235000013974 saffron Nutrition 0.000 claims description 3
- 239000004248 saffron Substances 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 2
- 102000003838 Sialyltransferases Human genes 0.000 claims description 2
- 108090000141 Sialyltransferases Proteins 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
- 235000011010 calcium phosphates Nutrition 0.000 claims description 2
- -1 cationic lipid Chemical class 0.000 claims description 2
- 238000004520 electroporation Methods 0.000 claims description 2
- 238000000520 microinjection Methods 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 102000004357 Transferases Human genes 0.000 claims 1
- 108090000992 Transferases Proteins 0.000 claims 1
- 210000002421 cell wall Anatomy 0.000 claims 1
- 210000003793 centrosome Anatomy 0.000 claims 1
- 210000004292 cytoskeleton Anatomy 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 210000003712 lysosome Anatomy 0.000 claims 1
- 230000001868 lysosomic effect Effects 0.000 claims 1
- 210000003705 ribosome Anatomy 0.000 claims 1
- 210000000056 organ Anatomy 0.000 abstract description 6
- 238000004458 analytical method Methods 0.000 abstract description 5
- 230000001939 inductive effect Effects 0.000 abstract 1
- 210000003763 chloroplast Anatomy 0.000 description 30
- 230000000694 effects Effects 0.000 description 30
- 229940079593 drug Drugs 0.000 description 28
- 239000003814 drug Substances 0.000 description 28
- 239000012528 membrane Substances 0.000 description 18
- 230000009466 transformation Effects 0.000 description 17
- 210000005061 intracellular organelle Anatomy 0.000 description 15
- 210000000805 cytoplasm Anatomy 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 13
- 230000032258 transport Effects 0.000 description 13
- KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 11
- JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- QDLHCMPXEPAAMD-QAIWCSMKSA-N wortmannin Chemical compound C1([C@]2(C)C3=C(C4=O)OC=C3C(=O)O[C@@H]2COC)=C4[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O QDLHCMPXEPAAMD-QAIWCSMKSA-N 0.000 description 11
- QDLHCMPXEPAAMD-UHFFFAOYSA-N wortmannin Natural products COCC1OC(=O)C2=COC(C3=O)=C2C1(C)C1=C3C2CCC(=O)C2(C)CC1OC(C)=O QDLHCMPXEPAAMD-UHFFFAOYSA-N 0.000 description 11
- 101710192640 Ribulose bisphosphate carboxylase/oxygenase activase Proteins 0.000 description 10
- 101710153769 Ribulose bisphosphate carboxylase/oxygenase activase, chloroplastic Proteins 0.000 description 10
- 239000003112 inhibitor Substances 0.000 description 10
- 241000219194 Arabidopsis Species 0.000 description 9
- 101000721927 Arabidopsis thaliana Outer envelope membrane protein 7 Proteins 0.000 description 9
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000007876 drug discovery Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000003752 polymerase chain reaction Methods 0.000 description 7
- 102000034285 signal transducing proteins Human genes 0.000 description 7
- 108091006024 signal transducing proteins Proteins 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 6
- XDHNQDDQEHDUTM-JQWOJBOSSA-N bafilomycin A1 Chemical compound CO[C@H]1\C=C\C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@]1(O)O[C@H](C(C)C)[C@@H](C)[C@H](O)C1 XDHNQDDQEHDUTM-JQWOJBOSSA-N 0.000 description 6
- XDHNQDDQEHDUTM-ZGOPVUMHSA-N bafilomycin A1 Natural products CO[C@H]1C=CC=C(C)C[C@H](C)[C@H](O)[C@H](C)C=C(C)C=C(OC)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@]1(O)O[C@H](C(C)C)[C@@H](C)[C@H](O)C1 XDHNQDDQEHDUTM-ZGOPVUMHSA-N 0.000 description 6
- XDHNQDDQEHDUTM-UHFFFAOYSA-N bafliomycin A1 Natural products COC1C=CC=C(C)CC(C)C(O)C(C)C=C(C)C=C(OC)C(=O)OC1C(C)C(O)C(C)C1(O)OC(C(C)C)C(C)C(O)C1 XDHNQDDQEHDUTM-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 238000013492 plasmid preparation Methods 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- JAPJOLBDXOXSKE-WQICJITCSA-N (2s)-2-[[(2s)-2-[[(e)-3-(furan-2-yl)prop-2-enoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)\C=C\C=1OC=CC=1)C1=CC=CC=C1 JAPJOLBDXOXSKE-WQICJITCSA-N 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000002547 new drug Substances 0.000 description 5
- 108010022172 Chitinases Proteins 0.000 description 4
- 102000012286 Chitinases Human genes 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000004899 c-terminal region Anatomy 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 102000014914 Carrier Proteins Human genes 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 3
- CZQHHVNHHHRRDU-UHFFFAOYSA-N LY294002 Chemical compound C1=CC=C2C(=O)C=C(N3CCOCC3)OC2=C1C1=CC=CC=C1 CZQHHVNHHHRRDU-UHFFFAOYSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 108700005075 Regulator Genes Proteins 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 108091008324 binding proteins Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- KQNZDYYTLMIZCT-KFKPYADVSA-N (2e,7s,10e,12r,13r,15s)-12,15-dihydroxy-7-methyl-8-oxabicyclo[11.3.0]hexadeca-2,10-dien-9-one Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\C2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KFKPYADVSA-N 0.000 description 2
- HKWJHKSHEWVOSS-OMDJCSNQSA-N 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate) Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(O)(=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O HKWJHKSHEWVOSS-OMDJCSNQSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101001096177 Homo sapiens Pleckstrin homology domain-containing family A member 3 Proteins 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102100037867 Pleckstrin homology domain-containing family A member 3 Human genes 0.000 description 2
- 108010041948 SNARE Proteins Proteins 0.000 description 2
- 102000000583 SNARE Proteins Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229930002868 chlorophyll a Natural products 0.000 description 2
- 229930002869 chlorophyll b Natural products 0.000 description 2
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000001177 diphosphate Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940000406 drug candidate Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000010189 intracellular transport Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000003412 trans-golgi network Anatomy 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- VLKSXJAPRDAENT-OWGHDAAGSA-N 3-[(3r,6r,9s,16s,19r,22s,25s)-3,9-bis(2-amino-2-oxoethyl)-16-[(1r)-1-hydroxyethyl]-19-(hydroxymethyl)-6-[(4-hydroxyphenyl)methyl]-13-octyl-2,5,8,11,15,18,21,24-octaoxo-1,4,7,10,14,17,20,23-octazabicyclo[23.3.0]octacosan-22-yl]propanoic acid Chemical compound C([C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)CC(NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(N)=O)NC1=O)CCCCCCCC)C1=CC=C(O)C=C1 VLKSXJAPRDAENT-OWGHDAAGSA-N 0.000 description 1
- 102000016954 ADP-Ribosylation Factors Human genes 0.000 description 1
- 108010053971 ADP-Ribosylation Factors Proteins 0.000 description 1
- 101150102703 BIP3 gene Proteins 0.000 description 1
- 101150097046 BIP5 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101001050162 Homo sapiens Early endosome antigen 1 Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 101710116435 Outer membrane protein Proteins 0.000 description 1
- 101150055906 PH gene Proteins 0.000 description 1
- 108091007960 PI3Ks Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102000010995 Pleckstrin homology domains Human genes 0.000 description 1
- 108050001185 Pleckstrin homology domains Proteins 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 102000015176 Proton-Translocating ATPases Human genes 0.000 description 1
- 108010039518 Proton-Translocating ATPases Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235343 Saccharomycetales Species 0.000 description 1
- 101710108867 Sporamin B Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 125000005340 bisphosphate group Chemical group 0.000 description 1
- HOZOZZFCZRXYEK-GSWUYBTGSA-M butylscopolamine bromide Chemical compound [Br-].C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)CCCC)=CC=CC=C1 HOZOZZFCZRXYEK-GSWUYBTGSA-M 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 108091000085 chlorophyll binding Proteins 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 210000005220 cytoplasmic tail Anatomy 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 238000001948 isotopic labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 102000006271 p21-Activated Kinases Human genes 0.000 description 1
- 108010058266 p21-Activated Kinases Proteins 0.000 description 1
- 108010055837 phosphocarrier protein HPr Proteins 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- GUUBJKMBDULZTE-UHFFFAOYSA-M potassium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[K+].OCCN1CCN(CCS(O)(=O)=O)CC1 GUUBJKMBDULZTE-UHFFFAOYSA-M 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000028973 vesicle-mediated transport Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Plant Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020010042886 | 2001-07-16 | ||
| KR1020010042886 | 2001-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20030007221A true KR20030007221A (ko) | 2003-01-23 |
Family
ID=19712212
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020020041787A Withdrawn KR20030007221A (ko) | 2001-07-16 | 2002-07-16 | 세포내 과정의 관측 방법 및 그를 위해 사용되는 재조합유전자 |
| KR1020047000440A Expired - Fee Related KR100919637B1 (ko) | 2001-07-16 | 2004-01-12 | 세포내 과정의 관측 및 신약 검색을 위한 시스템 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020047000440A Expired - Fee Related KR100919637B1 (ko) | 2001-07-16 | 2004-01-12 | 세포내 과정의 관측 및 신약 검색을 위한 시스템 |
Country Status (3)
| Country | Link |
|---|---|
| KR (2) | KR20030007221A (fr) |
| AU (1) | AU2002339228A1 (fr) |
| WO (2) | WO2003008536A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113039275A (zh) * | 2018-11-15 | 2021-06-25 | 巴伊沃爱普有限公司 | 用于在植物中表达病毒样颗粒的重组载体和用于使用该病毒样颗粒制备包含病毒样颗粒的疫苗组合物的方法 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030087869A1 (en) * | 2001-09-28 | 2003-05-08 | Ebens Allen James | Assay for compounds affecting invertebrate cell secretory pathways |
| KR100863283B1 (ko) * | 2002-10-11 | 2008-10-15 | 아람 바이오시스템 주식회사 | 세포내 과정의 관측 방법 및 그를 위해 사용되는 재조합유전자 |
| EP1799829B1 (fr) * | 2004-10-15 | 2012-01-18 | DSM IP Assets B.V. | Procede pour la production d'un compose dans une cellule eucaryote |
| FR2920878B1 (fr) * | 2007-09-10 | 2019-07-26 | Innovative Concepts In Drug Development (Icdd) | Procede de toxicologie predictive ou de test d'efficacite par mesure de mobilite d'organites |
| CN108676075B (zh) * | 2018-06-01 | 2022-04-01 | 山西省农业科学院果树研究所 | 一种引导蛋白分子进入植物细胞核的方法 |
| CN109136321A (zh) * | 2018-08-29 | 2019-01-04 | 北京艾普希隆生物科技有限公司 | 一种植物亚细胞定位试剂盒及其应用 |
| CN110734480B (zh) * | 2019-11-07 | 2021-08-24 | 中国科学院遗传与发育生物学研究所 | 大肠杆菌分子伴侣GroEL/ES在协助合成植物Rubisco中的应用 |
| CN114317593A (zh) * | 2021-12-31 | 2022-04-12 | 北京林业大学 | 一种超分辨显微技术观察植物原生质体膜蛋白动态的方法 |
| CN117230109B (zh) * | 2023-11-16 | 2024-03-19 | 三亚中国农业科学院国家南繁研究院 | 代替荧光蛋白的可视化质粒及其相关应用 |
| CN119101709A (zh) * | 2024-09-10 | 2024-12-10 | 深圳市第三人民医院(深圳市肝病研究所) | 人源trem2蛋白的双重荧光标记活细胞样品及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020192A (en) * | 1996-01-18 | 2000-02-01 | University Of Florida | Humanized green fluorescent protein genes and methods |
-
2002
- 2002-07-16 WO PCT/KR2002/001345 patent/WO2003008536A2/fr not_active Ceased
- 2002-07-16 WO PCT/IB2002/004257 patent/WO2003010507A2/fr not_active Ceased
- 2002-07-16 AU AU2002339228A patent/AU2002339228A1/en not_active Abandoned
- 2002-07-16 KR KR1020020041787A patent/KR20030007221A/ko not_active Withdrawn
-
2004
- 2004-01-12 KR KR1020047000440A patent/KR100919637B1/ko not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113039275A (zh) * | 2018-11-15 | 2021-06-25 | 巴伊沃爱普有限公司 | 用于在植物中表达病毒样颗粒的重组载体和用于使用该病毒样颗粒制备包含病毒样颗粒的疫苗组合物的方法 |
| US12156907B2 (en) | 2018-11-15 | 2024-12-03 | Bioapplications Inc. | Recombinant vector for expressing virus-like particles in plant and method for preparation of vaccine composition containing circovirus-like particles by using same |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002339228A1 (en) | 2003-02-17 |
| KR20040015804A (ko) | 2004-02-19 |
| WO2003010507A3 (fr) | 2004-05-27 |
| KR100919637B1 (ko) | 2009-09-30 |
| WO2003008536A2 (fr) | 2003-01-30 |
| WO2003010507A2 (fr) | 2003-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valdez‐Taubas et al. | Swf1‐dependent palmitoylation of the SNARE Tlg1 prevents its ubiquitination and degradation | |
| Rottensteiner et al. | Peroxisomal membrane proteins contain common Pex19p-binding sites that are an integral part of their targeting signals | |
| Wilkie et al. | Drosophila wingless and pair-rule transcripts localize apically by dynein-mediated transport of RNA particles | |
| Alzahofi et al. | Rab27a co-ordinates actin-dependent transport by controlling organelle-associated motors and track assembly proteins | |
| Yoshida et al. | The karyopherin Kap142p/Msn5p mediates nuclear import and nuclear export of different cargo proteins | |
| Fetchko et al. | Application of the split-ubiquitin membrane yeast two-hybrid system to investigate membrane protein interactions | |
| Kwon et al. | The chromokinesin, KLP3A, drives mitotic spindle pole separation during prometaphase and anaphase and facilitates chromatid motility | |
| KR20030007221A (ko) | 세포내 과정의 관측 방법 및 그를 위해 사용되는 재조합유전자 | |
| AU780574B2 (en) | Compound screening method | |
| JP2002526756A (ja) | 生細胞におけるタンパク質−タンパク質相互作用の測定方法 | |
| Saint-Jean et al. | The cytosolic tail dipeptide Ile-Met of the pea receptor BP80 is required for recycling from the prevacuole and for endocytosis | |
| Lanze et al. | Sur7 mediates a novel pathway for PI4, 5P2 regulation in C. albicans that promotes stress resistance and cell wall morphogenesis | |
| Lohia et al. | Dictyostelium discoideum Sir2D modulates cell-type specific gene expression and is involved in autophagy | |
| Seidel et al. | The Aspergillus nidulans kinesin-3 tail is necessary and sufficient to recognize modified microtubules | |
| Young et al. | Developmentally regulated Tcf7l2 splice variants mediate transcriptional repressor functions during eye formation | |
| Stepanik et al. | FGF pyramus has a transmembrane domain and cell-autonomous function in Polarity | |
| US20070264681A1 (en) | Cell Cycle Phase Markers | |
| KR100863283B1 (ko) | 세포내 과정의 관측 방법 및 그를 위해 사용되는 재조합유전자 | |
| AU752792B2 (en) | Methods and compositions for the determination of protein function and identification of modulators thereof | |
| Yang et al. | A mongolian pine specific endoplasmic reticulum localized CALMODULIN-LIKE calcium binding protein enhances arabidopsis growth | |
| Ben-Nissan et al. | Partitioning of casein kinase 1-like 6 to late endosome-like vesicles | |
| Nsamba | Molecular and functional characterization of tubulin isotypes in budding yeast (Saccharomyces cerevisiae) | |
| Sasmal | Mitotic Kinesin Motors: Insights on domain functions | |
| Lopez-Ochoa et al. | Isolation of peptide aptamers to target protein function | |
| Siao | Synaptotagmin 1 and Synaptic Vesicle Protein 2-like in Arabidopsis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20020716 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |